Results 1 to 10 of about 69,327 (216)

A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use [PDF]

Scientific Reports
Metamizole is an analgesic widely used after its introduction but later withdrawn in several countries due to the risk of agranulocytosis. Despite this, it remains frequently used worldwide.
Alessia Zinzi, Mario Gaio, Donatella Ruggiero, Consiglia Riccardi, Cecilia Cagnotta, Ciro Pentella, Annalisa Capuano, Concetta Rafaniello   +7 more
doaj   +2 more sources

Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study [PDF]

BMC Infectious Diseases
Introduction Although dolutegravir (DTG)-based HIV treatment has demonstrated superior efficacy, it has been associated with adverse drug reactions (ADRs).
Henry Zakumumpa, Helen Byomire Ndagije, Joanitah Atuhaire, Julius Mayengo, Francis Odipiyo, Kiguba Ronald   +5 more
doaj   +2 more sources

Pharmacovigilance

International Journal of Pharmaceutical Sciences Review and Research, 2021
Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life.
Adiba Nousheen, Asra Asra, Hasnat Fatima, Nashra Nizami, Sarah Noureen, Syed Amair Ali, B. Tazneem Tazneem, Syeda Zuleqaunnisa Begum   +7 more
  +7 more sources

Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management. [PDF]

Pharmacoepidemiol Drug Saf
Norén GN, Donegan K, Muñoz MA, Alshammari TM, Pratt N, Candore G, Morales D, Rijnbeek P, Bate A, Postigo R, Toh S, Trifirò G, Gabarro MS, Cave A, Ryan PB.   +14 more
europepmc   +3 more sources

Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers

Безопасность и риск фармакотерапии, 2021
Ensuring the safety of pharmacotherapy is a priority of the national regulatory health policy and is enshrined in the international and federal legislation.
A. E. Krasheninnikov, A. V. Matveev, S. D. Marchenko   +2 more
doaj   +1 more source

Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature

Frontiers in Immunology, 2023
BackgroundAlbeit the need for sex-disaggregated results of adverse events after immunization (AEFIs) is gaining attention since the COVID-19 pandemic, studies with emphasis on sexual dimorphism in response to COVID-19 vaccination are relatively scarce ...
Janneke W. Duijster, Thomas Lieber, Silvia Pacelli, Silvia Pacelli, Leontine Van Balveren, Loes S. Ruijs, Monika Raethke, Agnes Kant, Florence Van Hunsel   +8 more
doaj   +1 more source

Pharmacovigilance

International journal of health sciences, 2022
The World Health Organization (WHO) defines Pharmacovigilance as the science & activities relating to detection, assessment, understanding and prevention of adverse effects or any other drug related problem. The National Pharmacovigilance Programme (NPVP) was launched in 2004 with World Bank funding till 2009, which was renamed as Pharmacovigilance
Shruti Brahmbhatt, Mahavirsingh Rajput
openaire   +1 more source

Research Progress of Antitumor Pharmacovigilance

Chinese Journal of Lung Cancer, 2022
In 2019, Drug Administration Law of China was first time proposed that the country should establish pharmacovigilance system. In 2021, the first Pharmacovigilance Quality Management Standard of China was released.
Wenjuan SUN, Yang HU, Yan XU, Bo ZHANG
doaj   +1 more source

Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004–2015

BMC Infectious Diseases, 2021
Background Norovirus is an important cause of acute gastroenteritis globally. However, norovirus is rarely laboratory confirmed or recorded explicitly as a cause of hospitalization.
Elsa Negro Calduch, Tom Cattaert, Thomas Verstraeten   +2 more
doaj   +1 more source

Audits and inspections of pharmacovigilance systems in Russia

Качественная клиническая практика, 2023
The implementation of pharmacovigilance activities is impossible in isolation from compliance with the quality requirements of medicines and the activities of pharmaceutical and medical organizations throughout the pharmaceutical practice, as well as ...
A. A. Taube, B. K. Romanov
doaj   +1 more source